Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial compares a PD-1 antibody to best supportive care following chemoradiation in locoregionally advanced nasopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. [Phase 2]
Phase 2 trial of SHR-1210 in recurrent/metastatic nasopharyngeal carcinoma after at least two prior lines of chemotherapy has completed with…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating camrelizumab combined with chemotherapy and endoscopic surgery for recurrent nasopharyngeal carcinoma is…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study [Phase 1, Phase 2]
A head-to-head prospective comparison of two PET/CT tracers for nasopharyngeal carcinoma has been completed in a single center, spanning Pha…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis [Phase 3]
Phase 3 clinical trial evaluating bacterial decolonization to prevent radiation-induced oral mucositis in nasopharyngeal carcinoma patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2, Phase 3]
A multi-center randomized trial evaluating AK104 with chemotherapy vs placebo in second-line or later recurrent/metastatic nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating docetaxel and cisplatin with nimotuzumab as first-line therapy for recurrent or metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy [Phase 3]
A Phase 3 trial comparing reduced-dose radiotherapy with and without concurrent chemotherapy versus standard concurrent chemoradiation for h…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating PD-1 inhibitor with anti-EGFR therapy and radiotherapy for locally advanced nasopharyngeal carcinoma resis…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Phase II/III trial evaluating the efficacy and safety of QL1706 in patients with nasopharyngeal carcinoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy [Phase 2]
Phase 2 clinical trial evaluating anlotinib in recurrent or metastatic nasopharyngeal carcinoma after failure of at least second-line therap…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for KL-A167 injection in recurrent or metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC [Phase 3]
Phase 3 trial evaluating induction chemotherapy and immunotherapy combined radiotherapy with or without concurrent chemotherapy for stage II…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in nasopharyngeal carcinoma is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial [Phase 2]
Phase II open-label study evaluating PD-1 inhibitors plus chemoradiotherapy in metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: GNT Induction Treatment in Locally Advanced NPC [Phase 3]
Phase 3 trial update for GNT induction treatment in locally advanced nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) [Phase 1, Phase 2]
Phase 1/2a study of VK-2019 in EBV-positive nasopharyngeal carcinoma was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Anrotinib and Tirelizumab in First-line Treatment of RM-NPC [Phase 2]
Phase 2 clinical trial exploring anrotinib and tirelizumab as first-line treatment for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating multiple-dose JS004 in head and neck cancers, assessing safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients [Phase 2]
Phase II trial investigating neoadjuvant and adjuvant toripalimab with concurrent chemoradiotherapy in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients [Phase 3]
A Phase III trial evaluating chemotherapy and immunotherapy for advanced nasopharyngeal carcinoma has completed recruitment with results pos…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase II study evaluating Epstein-Barr virus–specific immunotherapy for nasopharyngeal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial updating chemoradiation regimens using cisplatin- or carboplatin-based therapy for locoregionally advanced nasopharyngeal carc…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating camrelizumab after radiotherapy in patients with oligometastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) [Phase 2]
Phase 2 trial investigating Epstein-Barr virus DNA response to systemic therapy for treatment adaptation in high-risk nasopharyngeal carcino…